VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to Camp Comprehensive Tax Reform draft (no specific bills); Issues related to the Orphan Drug Tax Credit (no specific bills)
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL WHITEFORD MACK | — |
| MICHAEL MATTOON | — |
Health Issues HCR
Issues related to regulatory reforms and drug development under the Energy & Commerce Committee's 21st Century Cures initiative (no specific bills); Issues related to access to rare and orphan disease therapeutics under the enactment of ACA (no specific bills); Issues related to FDA regulatory pathways for pharmaceuticals (no specific bills); H.R. 460 The Patients' Access to Treatments Act of 2013 (all provisions)
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL WHITEFORD MACK | — |
| MICHAEL MATTOON | — |
| SAMANTHA VENTIMIGLIA | — |
Medicare/Medicaid MMM
H.R. 2827/S. 1365 The Part D Beneficiary Appeals Fairness Act (all provisions).
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL WHITEFORD MACK | — |
| MICHAEL MATTOON | — |
| SAMANTHA VENTIMIGLIA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.